Navegar por autor "Gómez Caamaño, Antonio"

A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity

2014- Barnett, G. C.; Thompson, D.; Fachal Vilar, Laura; Kerns, S.; Talbot, C.; [et al.]

A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1

2014- Fachal Vilar, Laura; Vega Gliemmo, Ana; Carracedo Álvarez, Ángel; Sanchez Garcia, Manuel; Lobato Busto, Ramón; [et al.]

Androgen deprivation and radiotherapy in patients with prostate cancer and cardiovascular risk factors: clinical controversies

2015- Gómez Caamaño, Antonio

Androgen deprivation therapy and cardiovascular risk in patients with prostate cancer

2013- Gómez Caamaño, Antonio

Association of a XRCC3 polymorphism and rectum mean dose with the risk of acute radio-induced gastrointestinal toxicity in prostate cancer patients

2012- Fachal Vilar, Laura; Vega Gliemmo, Ana; Carracedo Álvarez, Ángel; Sanchez Garcia, Manuel; Lobato Busto, Ramón; [et al.]

Bone Turnover Markers and Potential Correlation with Outcomes in Patients with Genitourinary Cancer (Prostate) and Bone Metastasis (Results of Tugamo Study)

2012- Anido Herranz, Urbano; Gómez Caamaño, Antonio

BRCA1 mutations do not increase prostate cancer risk: Results from a meta-analysis including new data

2011- Fachal Vilar, Laura; Vega Gliemmo, Ana; Carracedo Álvarez, Ángel; Gómez Caamaño, Antonio; Peleteiro Higuero, Paula; [et al.]

Calidad de vida después recidiva bioquímica en los pacientes con cáncer de próstata. ¿Cómo y cuánto viven los pacientes después de recidiva bioquímica?

2012- León Mateos, Luis Ángel; Gómez Caamaño, Antonio; Peleteiro Higuero, Paula; Carballo Castro, Ana María; Taboada Valladares, Maria Begoña; [et al.]

Cancer de recto localmente avanzado. La necesidad de la superespecializacion

2015- Gómez Caamaño, Antonio; Peleteiro Higuero, Paula; Bustamante Montalvo, Manuel; Paredes Cotoré, Jesús; Fernández López, Fernando [et al.]

Consensus on management of castration-resistant prostate cancer on behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology

2019- Gómez Caamaño, Antonio; González-San Segundo, C.; Henríquez, I.; Maldonado, X.; Zapatero, A. [et al.]

CT perfusion in oncologic imaging: a useful tool?

2013- León Mateos, Luis Ángel; Gómez Caamaño, Antonio; Garrido Pumar, Miguel; Baleato Gonzalez, Sandra; García Figueiras, Roberto [et al.]

Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study

2020- Zapatero, A.; Gómez Caamaño, Antonio; Cabeza Rodriguez, M.; Muinelo Romay , Laura; Martin de Vidales, C.; [et al.]

Evaluating the role of mitochondrial DNA variation to the genetic predisposition to radiation-induced toxicity

2014- Fachal Vilar, Laura; Vega Gliemmo, Ana; Sanchez Garcia, Manuel; Lobato Busto, Ramón; Gómez Caamaño, Antonio; [et al.]

Factores pronosticos e imagen funcional del cancer de recto.

2012- Gómez Caamaño, Antonio; García Figueiras, Roberto; Caro Dominguez, Pablo; García Dorrego, Ramón María; Vázquez Martín, Alicia Maria [et al.]

Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer

2013- Kerns, S. L.; Stock, R. G.; Stone, N. N.; Blacksburg, S. R.; Rath, L.; [et al.]

GOECP/SEOR clinical recommendations for lung cancer radiotherapy during the COVID-19 pandemic

2020- Counago, F.; Navarro-Martin, A.; Luna, J.; de Dios, N. R.; Rodriguez, A.; [et al.]

High-dose neoadjuvant radiochemotherapy followed by surgery in MRI and EUS-defined poor-risk rectal cancer

2011- Iglesias García, Julio; Luna Vega, Victor; Gómez Caamaño, Antonio; Peleteiro Higuero, Paula; Carballo Castro, Ana María; [et al.]

Hiperfracctioned Radiochemotherapy in Small Cell Lung Cancer, a Monoinstutional Experience

2015- Lazaro Quintela, Martín; Gómez Caamaño, Antonio; Calvo Crespo, Patricia; Taboada Valladares, Maria Begoña

Identification of a Locus at 2q24 Associated With Susceptibility for Late Radiation Therapy Toxicity Through Performance of a 3-Stage Genome-Wide Association Study

2014- Fachal Vilar, Laura; Vega Gliemmo, Ana; Gómez Caamaño, Antonio

Imaging of Tumor Angiogenesis for Radiologists--Part 1: Biological and Technical Basis

2015- Gómez Caamaño, Antonio; Baleato Gonzalez, Sandra; García Figueiras, Roberto

Repositorio digital RUNA

Navegar por autor "Gómez Caamaño, Antonio"

A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity ﻿

A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1 ﻿

Androgen deprivation and radiotherapy in patients with prostate cancer and cardiovascular risk factors: clinical controversies ﻿

Androgen deprivation therapy and cardiovascular risk in patients with prostate cancer ﻿

Association of a XRCC3 polymorphism and rectum mean dose with the risk of acute radio-induced gastrointestinal toxicity in prostate cancer patients ﻿

Bone Turnover Markers and Potential Correlation with Outcomes in Patients with Genitourinary Cancer (Prostate) and Bone Metastasis (Results of Tugamo Study) ﻿

BRCA1 mutations do not increase prostate cancer risk: Results from a meta-analysis including new data ﻿

Calidad de vida después recidiva bioquímica en los pacientes con cáncer de próstata. ¿Cómo y cuánto viven los pacientes después de recidiva bioquímica? ﻿

Cancer de recto localmente avanzado. La necesidad de la superespecializacion ﻿

Consensus on management of castration-resistant prostate cancer on behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology ﻿

CT perfusion in oncologic imaging: a useful tool? ﻿

Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study ﻿

Evaluating the role of mitochondrial DNA variation to the genetic predisposition to radiation-induced toxicity ﻿

Factores pronosticos e imagen funcional del cancer de recto. ﻿

Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer ﻿

GOECP/SEOR clinical recommendations for lung cancer radiotherapy during the COVID-19 pandemic ﻿

High-dose neoadjuvant radiochemotherapy followed by surgery in MRI and EUS-defined poor-risk rectal cancer ﻿

Hiperfracctioned Radiochemotherapy in Small Cell Lung Cancer, a Monoinstutional Experience ﻿

Identification of a Locus at 2q24 Associated With Susceptibility for Late Radiation Therapy Toxicity Through Performance of a 3-Stage Genome-Wide Association Study ﻿

Imaging of Tumor Angiogenesis for Radiologists--Part 1: Biological and Technical Basis ﻿

A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity

A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1

Androgen deprivation and radiotherapy in patients with prostate cancer and cardiovascular risk factors: clinical controversies

Androgen deprivation therapy and cardiovascular risk in patients with prostate cancer

Association of a XRCC3 polymorphism and rectum mean dose with the risk of acute radio-induced gastrointestinal toxicity in prostate cancer patients

Bone Turnover Markers and Potential Correlation with Outcomes in Patients with Genitourinary Cancer (Prostate) and Bone Metastasis (Results of Tugamo Study)

BRCA1 mutations do not increase prostate cancer risk: Results from a meta-analysis including new data

Calidad de vida después recidiva bioquímica en los pacientes con cáncer de próstata. ¿Cómo y cuánto viven los pacientes después de recidiva bioquímica?

Cancer de recto localmente avanzado. La necesidad de la superespecializacion

Consensus on management of castration-resistant prostate cancer on behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology

CT perfusion in oncologic imaging: a useful tool?

Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study

Evaluating the role of mitochondrial DNA variation to the genetic predisposition to radiation-induced toxicity

Factores pronosticos e imagen funcional del cancer de recto.

Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer

GOECP/SEOR clinical recommendations for lung cancer radiotherapy during the COVID-19 pandemic

High-dose neoadjuvant radiochemotherapy followed by surgery in MRI and EUS-defined poor-risk rectal cancer

Hiperfracctioned Radiochemotherapy in Small Cell Lung Cancer, a Monoinstutional Experience

Identification of a Locus at 2q24 Associated With Susceptibility for Late Radiation Therapy Toxicity Through Performance of a 3-Stage Genome-Wide Association Study

Imaging of Tumor Angiogenesis for Radiologists--Part 1: Biological and Technical Basis